Skip to Content

Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy (TNT)

In this MEDtalk from the ASCO GI conference, Dr. Yun Sung presents a study that evaluates survival outcomes for patients receiving TNT and gastric resection, including 203 patients, primarily treated with induction chemotherapy using 5-FU and oxaliplatin, followed by chemoradiation.

Yun Sung

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top